Inactivating mutations of KDM5C, commonly found in patients with ccRCC, alter glycogen metabolism, leading to increased NADPH and GSH levels and thereby inhibiting ferroptosis
Programs may start from a customer-supplied small molecule, an expected metabolite structure, or a labeled-handle concept, and can be aligned with broader amino acid conjugation, custom bioconjugation services, or thiol-reactive route planning informed by maleimide conjugation considerations when appropriate
Shamsuzzaman, A
Interest in FOXO4-DRI has been driven by studies investigating cellular senescence, transcription factor signaling, and age-related cellular processes
D., Green, A
Research demonstrates that it promotes synapse formation at approximately 10 million times the potency of BDNF itself, working through the hepatocyte growth factor (HGF) and c-Met receptor pathway